Blood Cancer TreatmentsDrugs Jakavi A Targeted Therapy for Blood Cancers Tony Gates October 29, 2024 Jakavi, a JAK1/JAK2 inhibitor, stands as a beacon of hope for patients battling certain blood cancers. This targeted therapy works by interfering with the signaling